These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 836970)

  • 21. Fibrinogen Bondy: a new case of dysfibrinogenemia. Isolation of the abnormal fibrinogen molecules.
    Jandrot-Perrus M; Aurousseau MH; Rabiet MJ; Josso F
    Thromb Res; 1982 Sep; 27(6):659-70. PubMed ID: 6217586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An abnormal fibrinogen with delayed fibrinopeptide A release.
    Lane DA; VanRoss M; Kakkar VV; Bottomley KJ; Dhir K; Holt LP; MacIver JE
    Br J Haematol; 1980 Sep; 46(1):89-98. PubMed ID: 7426452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release.
    Lane DA; Cuddigan B; VanRoss M; Kakkar VV
    Br J Haematol; 1980 Mar; 44(3):483-94. PubMed ID: 6769460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interpretation of screening tests of hemostasis].
    Wuillemin WA; Heizmann M
    Praxis (Bern 1994); 2003 Jan; 92(3):57-64. PubMed ID: 12577721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary dysfibrinogenemia.
    Bithell TC
    Clin Chem; 1985 Apr; 31(4):509-16. PubMed ID: 3978780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinogen Marburg a new genetic variant of fibrinogen.
    Fuchs G; Egbring R; Havemann K
    Blut; 1977 Feb; 34(2):107-18. PubMed ID: 836966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Disorders in the conversion of fibrinogen to fibrin in patients with multiple myeloma].
    Lopaciuk S; Snigurowicz J; Rostkowska J; Pniejnia-Olszyński W; Powiertowska-Rezmer M
    Acta Haematol Pol; 1978; 9(3):157-64. PubMed ID: 102100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The kaolin clotting time; a rapid one-stage method for diagnosis of coagulation defects.
    MARGOLIS J
    J Clin Pathol; 1958 Sep; 11(5):406-9. PubMed ID: 13575555
    [No Abstract]   [Full Text] [Related]  

  • 29. International council for standardisation in haematology recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders.
    Mackie I; Casini A; Pieters M; Pruthi R; Reilly-Stitt C; Suzuki A
    Int J Lab Hematol; 2024 Feb; 46(1):20-32. PubMed ID: 37984807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinogen kaiserslautern III: a new case of congenital dysfibrinogenemia with aalpha 16 arg-->cys substitution.
    Loreth RM; Meyer M; Albert FW
    Haemostasis; 2001; 31(1):12-7. PubMed ID: 11408744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed hemostatic changes following cardiopulmonary bypass.
    Davey FR; Parker FB
    Am J Med Sci; 1976; 271(2):171-8. PubMed ID: 1266888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and therapy of bleeding of plasmatic origine].
    Linke H
    Dtsch Gesundheitsw; 1966 Jun; 21(26):1201-6. PubMed ID: 5955615
    [No Abstract]   [Full Text] [Related]  

  • 33. Circulating thrombin time anticoagulant in a procainamide-induced syndrome.
    Galanakis DK; Newman J; Summers D
    JAMA; 1978 May; 239(18):1873-4. PubMed ID: 642115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Usefulness of a modified thrombin generation test in the diagnosis of chronometric hypercoagulability].
    Zawilska K; Furmaniuk J
    Acta Haematol Pol; 1972; 3(2):155-60. PubMed ID: 4655614
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the diagnosis of blood coagulation disorders in obstetrics by means of the thrombin time determination].
    Slunský R; Kalita Z; Adamcová M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 91(4):465-71. PubMed ID: 4184473
    [No Abstract]   [Full Text] [Related]  

  • 36. Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.
    d'Audigier C; Delassasseigne C; Robert A; Eschwège V
    Int J Lab Hematol; 2016 Feb; 38(1):50-3. PubMed ID: 26406495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulating effect on tissue-type plasminogen activator--a new and sensitive indicator of denatured fibrinogen.
    Haddeland U; Bennick A; Brosstad F
    Thromb Res; 1995 Feb; 77(4):329-36. PubMed ID: 7740524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Functional analysis for dysfibrinogenemias, Toyama and Adachi, which have a mutation of Aalpha16Arg-->His (CGT-->CAT) with aberrant fibrinopeptide A release].
    Soya K; Takezawa Y; Terasawa F; Okumura N
    Rinsho Byori; 2012 Jun; 60(6):499-505. PubMed ID: 22880226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).
    Bögli C; Hofer A; Baudo F; Redaelli R; Furlan M
    Haemostasis; 1992; 22(1):7-11. PubMed ID: 1521828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Coagulation disorders in the intensive care station].
    Hart C; Spannagl M
    Internist (Berl); 2014 May; 55(5):521-8. PubMed ID: 24715275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.